BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ishak RAH, Mostafa NM, Kamel AO. Stealth lipid polymer hybrid nanoparticles loaded with rutin for effective brain delivery - comparative study with the gold standard (Tween 80): optimization, characterization and biodistribution. Drug Deliv 2017;24:1874-90. [PMID: 29191047 DOI: 10.1080/10717544.2017.1410263] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Paramanick D, Singh VD, Singh VK. Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases. Journal of Controlled Release 2022;351:638-655. [DOI: 10.1016/j.jconrel.2022.09.058] [Reference Citation Analysis]
2 Elhassan E, Devnarain N, Mohammed M, Govender T, Omolo CA. Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections. Journal of Controlled Release 2022;351:598-622. [DOI: 10.1016/j.jconrel.2022.09.052] [Reference Citation Analysis]
3 Alfaleh MA, Hashem AM, Abujamel TS, Alhakamy NA, Kalam MA, Riadi Y, Md S. Apigenin Loaded Lipoid–PLGA–TPGS Nanoparticles for Colon Cancer Therapy: Characterization, Sustained Release, Cytotoxicity, and Apoptosis Pathways. Polymers 2022;14:3577. [DOI: 10.3390/polym14173577] [Reference Citation Analysis]
4 Xie J, Zhong C, Wang T, He D, Lu L, Yang J, Yuan Z, Zhang J. Better Bioactivity, Cerebral Metabolism and Pharmacokinetics of Natural Medicine and Its Advanced Version. Front Pharmacol 2022;13:937075. [DOI: 10.3389/fphar.2022.937075] [Reference Citation Analysis]
5 Rawal SU, Patel BM, Patel MM. New Drug Delivery Systems Developed for Brain Targeting. Drugs 2022. [PMID: 35596879 DOI: 10.1007/s40265-022-01717-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zagalo DM, Silva BM, Silva C, Simões S, Sousa JJ. A quality by design (QbD) approach in pharmaceutical development of lipid-based nanosystems: A systematic review. Journal of Drug Delivery Science and Technology 2022;70:103207. [DOI: 10.1016/j.jddst.2022.103207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Singh B, Sharma T, Kaur R, Saini S, Kaur R, Beg S. QbD-Steered Systematic Development of Drug Delivery Nanoconstructs: Vital Precepts, Retrospect and Prospects. Biomedical Translational Research 2022. [DOI: 10.1007/978-981-16-9232-1_18] [Reference Citation Analysis]
8 Desai HR, Shinde UA. Hybrid nanoparticles to cross the blood–brain barrier. Nanocarriers for Drug-Targeting Brain Tumors 2022. [DOI: 10.1016/b978-0-323-90773-6.00002-6] [Reference Citation Analysis]
9 Gusmão LA, Tedesco AC. Polymer–lipid hybrid nanostructures for drug delivery. Hybrid Nanomaterials for Drug Delivery 2022. [DOI: 10.1016/b978-0-323-85754-3.00003-4] [Reference Citation Analysis]
10 Lokhande S, Shinde UA, Shrivastava A, Singh KH. Targeting of lipid/polymeric (hybrid) nanoparticles to brain tumors. Nanocarriers for Drug-Targeting Brain Tumors 2022. [DOI: 10.1016/b978-0-323-90773-6.00027-0] [Reference Citation Analysis]
11 Gagliardi M, Cecchini M. Bio-inspired nanoparticles as drug delivery vectors. Nanoparticle Therapeutics 2022. [DOI: 10.1016/b978-0-12-820757-4.00002-8] [Reference Citation Analysis]
12 Teja PK, Mithiya J, Kate AS, Bairwa K, Chauthe SK. Herbal nanomedicines: Recent advancements, challenges, opportunities and regulatory overview. Phytomedicine 2021;96:153890. [PMID: 35026510 DOI: 10.1016/j.phymed.2021.153890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Patel M, Patel P. Toxicity and Safety Evaluation of Lipid‐Based Nanoparticles for Brain Delivery. Nanotechnology in Medicine 2021. [DOI: 10.1002/9781119769897.ch10] [Reference Citation Analysis]
14 Han HS, Koo SY, Choi KY. Emerging nanoformulation strategies for phytocompounds and applications from drug delivery to phototherapy to imaging. Bioactive Materials 2021. [DOI: 10.1016/j.bioactmat.2021.11.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Elmeligy S, Hathout RM, Khalifa SA, El-seedi HR, Farag MA. Pharmaceutical manipulation of citrus flavonoids towards improvement of its bioavailability and stability. A mini review and a meta-analysis study. Food Bioscience 2021;44:101428. [DOI: 10.1016/j.fbio.2021.101428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Abdel-Naby DH, Deghiedy NM, Rashed RR, El-Ghazaly MA. Tailoring of chitosan/diacrylated pluronic system as a versatile nanoplatform for the amelioration of radiation-induced cognitive dysfunction. Int J Biol Macromol 2021:S0141-8130(21)02379-5. [PMID: 34740686 DOI: 10.1016/j.ijbiomac.2021.10.214] [Reference Citation Analysis]
17 Khater SE, El-Khouly A, Abdel-Bar HM, Al-Mahallawi AM, Ghorab DM. Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection. Int J Pharm 2021;607:121023. [PMID: 34416332 DOI: 10.1016/j.ijpharm.2021.121023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Abdel-Bar HM, Abdallah IA, Fayed MAA, Moatasim Y, Mostafa A, El-Behairy MF, Elimam H, Elshaier YAMM, Abouzid KAM. Lipid polymer hybrid nanocarriers as a combinatory platform for different anti-SARS-CoV-2 drugs supported by computational studies. RSC Adv 2021;11:28876-91. [PMID: 35478590 DOI: 10.1039/d1ra04576h] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Singh AK, Singh SS, Rathore AS, Singh SP, Mishra G, Awasthi R, Mishra SK, Gautam V, Singh SK. Lipid-Coated MCM-41 Mesoporous Silica Nanoparticles Loaded with Berberine Improved Inhibition of Acetylcholine Esterase and Amyloid Formation. ACS Biomater Sci Eng 2021;7:3737-53. [PMID: 34297529 DOI: 10.1021/acsbiomaterials.1c00514] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
20 Miyazawa T, Itaya M, Burdeos GC, Nakagawa K, Miyazawa T. A Critical Review of the Use of Surfactant-Coated Nanoparticles in Nanomedicine and Food Nanotechnology. Int J Nanomedicine 2021;16:3937-99. [PMID: 34140768 DOI: 10.2147/IJN.S298606] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 25.0] [Reference Citation Analysis]
21 Islam Y, Leach AG, Smith J, Pluchino S, Coxon CR, Sivakumaran M, Downing J, Fatokun AA, Teixidò M, Ehtezazi T. Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles. Adv Sci (Weinh) 2021;8:e2002085. [PMID: 34105297 DOI: 10.1002/advs.202002085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
22 Abdel-Bar HM, Walters AA, Wang JT, Al-Jamal KT. Combinatory Delivery of Etoposide and siCD47 in a Lipid Polymer Hybrid Delays Lung Tumor Growth in an Experimental Melanoma Lung Metastatic Model. Adv Healthc Mater 2021;10:e2001853. [PMID: 33661553 DOI: 10.1002/adhm.202001853] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
23 Abbas M. Potential Role of Nanoparticles in Treating the Accumulation of Amyloid-Beta Peptide in Alzheimer's Patients. Polymers (Basel) 2021;13:1051. [PMID: 33801619 DOI: 10.3390/polym13071051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
24 Hamdi M, Abdel-Bar HM, Elmowafy E, El-Khouly A, Mansour M, Awad GAS. Investigating the Internalization and COVID-19 Antiviral Computational Analysis of Optimized Nanoscale Zinc Oxide. ACS Omega 2021;6:6848-60. [PMID: 33748599 DOI: 10.1021/acsomega.0c06046] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 19.0] [Reference Citation Analysis]
25 Abou Assi R, Abdulbaqi IM, Siok Yee C. The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. Pharmaceuticals (Basel) 2021;14:215. [PMID: 33806527 DOI: 10.3390/ph14030215] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 De Gaetano F, Cristiano MC, Venuti V, Crupi V, Majolino D, Paladini G, Acri G, Testagrossa B, Irrera A, Paolino D, Tommasini S, Ventura CA, Stancanelli R. Rutin-Loaded Solid Lipid Nanoparticles: Characterization and In Vitro Evaluation. Molecules 2021;26:1039. [PMID: 33669321 DOI: 10.3390/molecules26041039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
27 Gagliardi A, Paolino D, Costa N, Fresta M, Cosco D. Zein- vs PLGA-based nanoparticles containing rutin: A comparative investigation. Materials Science and Engineering: C 2021;118:111538. [DOI: 10.1016/j.msec.2020.111538] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 27.0] [Reference Citation Analysis]
28 Bera H, Abbasi YF, Hoong AK, Be LP, Wuan TJ, Guo H, Cun D, Yang M, Seen LY, Woan LL, Ying SQ. Functionalized Food-Grade Biopolymer-Nanosilica Based Hybrid Hydrogels as Sustained Delivery Devices of Rutin. J Polym Environ 2021;29:260-270. [DOI: 10.1007/s10924-020-01876-8] [Reference Citation Analysis]
29 Awadeen RH, Boughdady MF, Meshali MM. Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles - Formulation and Pharmacodynamic Assessment. Int J Nanomedicine 2020;15:8553-68. [PMID: 33173292 DOI: 10.2147/IJN.S274352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Pandian SRK, Pavadai P, Vellaisamy S, Ravishankar V, Palanisamy P, Sundar LM, Chandramohan V, Sankaranarayanan M, Panneerselvam T, Kunjiappan S. Formulation and evaluation of rutin-loaded solid lipid nanoparticles for the treatment of brain tumor. Naunyn Schmiedebergs Arch Pharmacol 2021;394:735-49. [PMID: 33156389 DOI: 10.1007/s00210-020-02015-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
31 Abdel-Bar HM, Khater SE, Ghorab DM, Al-Mahallawi AM. Hexosomes as Efficient Platforms for Possible Fluoxetine Hydrochloride Repurposing with Improved Cytotoxicity against HepG2 Cells. ACS Omega 2020;5:26697-709. [PMID: 33110996 DOI: 10.1021/acsomega.0c03569] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
32 da Silva FMA, da Silva KPA, de Oliveira LPM, Costa EV, Koolen HH, Pinheiro MLB, de Souza AQL, de Souza ADL. Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp). Mem Inst Oswaldo Cruz 2020;115:e200207. [PMID: 33027419 DOI: 10.1590/0074-02760200207] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
33 Binda A, Murano C, Rivolta I. Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer's Disease: A State-of-the-Art (2017-2020). Int J Nanomedicine 2020;15:6113-35. [PMID: 32884267 DOI: 10.2147/IJN.S231480] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
34 Huang Z, Huang Y, Wang W, Fu F, Wang W, Dang S, Li C, Ma C, Zhang X, Zhao Z, Pan X, Wu C. Relationship between particle size and lung retention time of intact solid lipid nanoparticle suspensions after pulmonary delivery. J Control Release 2020;325:206-22. [PMID: 32619747 DOI: 10.1016/j.jconrel.2020.06.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
35 Yokel RA. Nanoparticle brain delivery: a guide to verification methods. Nanomedicine 2020;15:409-32. [DOI: 10.2217/nnm-2019-0169] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
36 Hamdi M, Abdel-Bar HM, Elmowafy E, Al-Jamal KT, Awad GAS. An integrated vitamin E-coated polymer hybrid nanoplatform: A lucrative option for an enhanced in vitro macrophage retention for an anti-hepatitis B therapeutic prospect. PLoS One 2020;15:e0227231. [PMID: 31923260 DOI: 10.1371/journal.pone.0227231] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
37 Pedrozo RC, Antônio E, Khalil NM, Mainardes RM. Bovine serum albumin-based nanoparticles containing the flavonoid rutin produced by nano spray drying. Braz J Pharm Sci 2020;56:e17692. [DOI: 10.1590/s2175-97902019000317692] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
38 Mazur J, Roy K, Shigdar S, Kanwar JR. Efficacy of promising flavonoids from Festuca, Lonicera, and Acacia genera against glioblastoma multiforme; potential for the Dandenong Ranges. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents 2020. [DOI: 10.1016/b978-0-12-819666-3.00013-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Higazy IM. Brain targeting stealth lipomers of combined antiepileptic-anti-inflammatory drugs as alternative therapy for conventional anti-Parkinson's. Saudi Pharm J 2020;28:33-57. [PMID: 31920431 DOI: 10.1016/j.jsps.2019.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
40 Rashidinejad A, Loveday SM, Jameson GB, Hindmarsh JP, Singh H. Rutin-casein co-precipitates as potential delivery vehicles for flavonoid rutin. Food Hydrocolloids 2019;96:451-62. [DOI: 10.1016/j.foodhyd.2019.05.032] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
41 Maji R, Omolo CA, Agrawal N, Maduray K, Hassan D, Mokhtar C, Mackhraj I, Govender T. pH-Responsive Lipid–Dendrimer Hybrid Nanoparticles: An Approach To Target and Eliminate Intracellular Pathogens. Mol Pharmaceutics 2019;16:4594-609. [DOI: 10.1021/acs.molpharmaceut.9b00713] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 9.7] [Reference Citation Analysis]
42 Dibaei M, Rouini MR, Sheikholeslami B, Gholami M, Dinarvand R. The effect of surface treatment on the brain delivery of curcumin nanosuspension: in vitro and in vivo studies. Int J Nanomedicine 2019;14:5477-90. [PMID: 31409999 DOI: 10.2147/IJN.S199624] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
43 Maghrebi S, Prestidge CA, Joyce P. An update on polymer-lipid hybrid systems for improving oral drug delivery. Expert Opin Drug Deliv 2019;16:507-24. [PMID: 30957577 DOI: 10.1080/17425247.2019.1605353] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 8.7] [Reference Citation Analysis]
44 Abdel-messih HA, Ishak RA, Geneidi AS, Mansour S. Tailoring novel soft nano-vesicles ‘Flexosomes’ for enhanced transdermal drug delivery: Optimization, characterization and comprehensive ex vivo – in vivo evaluation. International Journal of Pharmaceutics 2019;560:101-15. [DOI: 10.1016/j.ijpharm.2019.01.072] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
45 Huang J, Huang W, Zhang Z, Lin X, Lin H, Peng L, Chen T. Highly Uniform Synthesis of Selenium Nanoparticles with EGFR Targeting and Tumor Microenvironment-Responsive Ability for Simultaneous Diagnosis and Therapy of Nasopharyngeal Carcinoma. ACS Appl Mater Interfaces 2019;11:11177-93. [PMID: 30821437 DOI: 10.1021/acsami.8b22678] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 15.7] [Reference Citation Analysis]
46 Soudi SA, Nounou MI, Sheweita SA, Ghareeb DA, Younis LK, El-khordagui LK. Protective effect of surface-modified berberine nanoparticles against LPS-induced neurodegenerative changes: a preclinical study. Drug Deliv and Transl Res 2019;9:906-19. [DOI: 10.1007/s13346-019-00626-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
47 Gharehbeglou P, Jafari SM, Hamishekar H, Homayouni A, Mirzaei H. Pectin-whey protein complexes vs. small molecule surfactants for stabilization of double nano-emulsions as novel bioactive delivery systems. Journal of Food Engineering 2019;245:139-48. [DOI: 10.1016/j.jfoodeng.2018.10.016] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 24.0] [Reference Citation Analysis]